Clinicopathological correlation of cerebrospinal fluid alpha‐synuclein seed amplification assay in a...
Clinicopathological correlation of cerebrospinal fluid alpha‐synuclein seed amplification assay in a behavioral neurology autopsy cohort
About this item
Full title
Author / Creator
Samudra, Niyatee , Fischer, D. Luke , Lenio, Steven , Lario Lago, Argentina , Ljubenkov, Peter A. , Rojas, Julio C. , Seeley, William W. , Spina, Salvatore , Staffaroni, Adam M. , Tablante, Jonathan , Wekselman, Fattin , Lamoureux, Jennifer , Concha‐Marambio, Luis , Grinberg, Lea T. , Boxer, Adam L. and VandeVrede, Lawren
Publisher
United States: John Wiley and Sons Inc
Journal title
Language
English
Formats
Publication information
Publisher
United States: John Wiley and Sons Inc
Subjects
More information
Scope and Contents
Contents
INTRODUCTION
Lewy body disease (LBD) is a common primary or co‐pathology in neurodegenerative syndromes. An alpha‐synuclein seed amplification assay (αSyn‐SAA) is clinically available, but clinical performance, especially lower sensitivity in amygdala‐predominant cases, is not well understood.
METHODS
Antemortem CSF from neuropathology‐con...
Alternative Titles
Full title
Clinicopathological correlation of cerebrospinal fluid alpha‐synuclein seed amplification assay in a behavioral neurology autopsy cohort
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11095442
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11095442
Other Identifiers
ISSN
1552-5260,1552-5279
E-ISSN
1552-5279
DOI
10.1002/alz.13799
